Dixyrazine: Difference between revisions
Content deleted Content added
Updating {{chembox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [ |
+ Legal status in Brazil |
||
(23 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{chembox |
{{chembox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
|Section1={{Chembox Identifiers |
|Section1={{Chembox Identifiers |
||
⚫ | |||
| |
| CASNo=2470-73-7 |
||
| |
| PubChem=17182 |
||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 7H368W3AYC |
| UNII = 7H368W3AYC |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 16265 |
|||
| EINECS = 219-591-3 |
|||
| SMILES=CC(CN1CCN(CC1)CCOCCO)CN2C3=CC=CC=C3SC4=CC=CC=C42 |
| SMILES=CC(CN1CCN(CC1)CCOCCO)CN2C3=CC=CC=C3SC4=CC=CC=C42 |
||
| InChI = 1/C24H33N3O2S/c1-20(18-26-12-10-25(11-13-26)14-16-29-17-15-28)19-27-21-6-2-4-8-23(21)30-24-9-5-3-7-22(24)27/h2-9,20,28H,10-19H2,1H3 |
|||
| InChIKey = MSYUMPGNGDNTIQ-UHFFFAOYAI |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C24H33N3O2S/c1-20(18-26-12-10-25(11-13-26)14-16-29-17-15-28)19-27-21-6-2-4-8-23(21)30-24-9-5-3-7-22(24)27/h2-9,20,28H,10-19H2,1H3 |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = MSYUMPGNGDNTIQ-UHFFFAOYSA-N |
|||
| KEGG_Ref = {{keggcite|changed|kegg}} |
|||
| KEGG = D07865 |
|||
}} |
}} |
||
|Section2={{Chembox Properties |
|Section2={{Chembox Properties |
||
| |
| Formula=C<sub>24</sub>H<sub>33</sub>N<sub>3</sub>O<sub>2</sub>S |
||
| |
| MolarMass=427.60272 g/mol |
||
| |
| Appearance= |
||
| |
| Density= |
||
| |
| MeltingPt= |
||
| |
| BoilingPt= |
||
| |
| Solubility= |
||
}} |
}} |
||
| |
|Section6={{Chembox Pharmacology |
||
| ATCCode_prefix = N05 |
|||
⚫ | |||
| ATCCode_suffix = AB01 |
|||
⚫ | |||
}} |
|||
| Autoignition= |
|||
|Section7={{Chembox Legal status |
|||
| legal_AU = |
|||
| legal_BR = C1 |
|||
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-04-04}}</ref> |
|||
| legal_US = |
|||
| legal_UK = |
|||
| legal_UN = |
|||
}} |
|||
|Section8={{Chembox Hazards |
|||
⚫ | |||
⚫ | |||
| AutoignitionPt = |
|||
}} |
}} |
||
}} |
}} |
||
'''Dixyrazine''' is |
'''Dixyrazine''', also known as '''dixypazin''' ([[oxalate]]), sold under the brand names '''Ansiolene''', '''Esocalm''', '''Esucos''', '''Metronal''', and '''Roscal''', is a [[typical antipsychotic]] of the [[phenothiazine]] group described as a [[neuroleptic]] and [[antihistamine]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA462|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=462–}}</ref> It was first introduced in Germany in 1969. It is used as a neuroleptic, [[anxiolytic]], and antihistamine in doses between 12.5 and 75 mg a day. |
||
==Synthesis== |
|||
[[File:Dixyrazine synthesis.svg|thumb|center|500px|[https://pharmaceutical-substances.thieme.com/ps/search-results?docUri=KD-04-0132 Thieme] Patent:<ref>Henri Morren, {{Cite patent|GB861420}} (1961).</ref>]] |
|||
Sodamide alkylation of [[phenothiazine]] ('''1''') with 1-bromo-3-chloro-2-methylpropane [6974-77-2] ('''2''') gives 10-(3-Chloro-2-methylpropyl)phenothiazine, [https://pubchem.ncbi.nlm.nih.gov/compound/12299119 CID:12299119] ('''3'''). Completion of the sidechain by alkylation with 1-[2-(2-Hydroxyethoxy) Ethyl]Piperazine [13349-82-1] ('''4''') and displacement of the halogen completes the synthesis of ''Dixyrazine'' ('''5'''). |
|||
==References== |
|||
{{Reflist|2}} |
|||
{{Antipsychotics}} |
|||
{{Dopamine receptor modulators}} |
|||
{{Histamine receptor modulators}} |
|||
[[Category:Primary alcohols]] |
|||
[[Category:Dopamine antagonists]] |
|||
[[Category:Ethers]] |
|||
[[Category:H1 receptor antagonists]] |
|||
[[Category:Phenothiazines]] |
[[Category:Phenothiazines]] |
||
[[Category:Piperazines]] |
[[Category:Piperazines]] |
||
[[Category: |
[[Category:Typical antipsychotics]] |
||
[[Category: |
[[Category:Ethanolamines]] |
||
⚫ | |||
⚫ | |||
[[fi:Diksyratsiini]] |
|||
[[sv:Dixyrazin]] |